Cancer cell cells anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Cell Line, Tumor Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Cell Line Neoplastic Stem Cells HeLa Cells Mitochondria Breast Spheroids, Cellular Fibroblasts Hep G2 Cells Cell Nucleus

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae

Diseases38

Neoplasms Breast Neoplasms Radiation Injuries Colonic Neoplasms Lung Neoplasms Ovarian Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Neoplasm Metastasis Stomach Neoplasms Adenocarcinoma Neoplasms, Radiation-Induced Prostatic Neoplasms Carcinoma Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Radiation Injuries, Experimental Cell Transformation, Neoplastic Radiation Pneumonitis Uterine Cervical Neoplasms Urinary Bladder Neoplasms Disease Progression Neoplasms, Experimental Neovascularization, Pathologic Head and Neck Neoplasms Liver Neoplasms Neoplasms, Hormone-Dependent Neoplasm Recurrence, Local Bone Neoplasms Brain Neoplasms Mammary Neoplasms, Experimental Carcinoma, Small Cell Melanoma Endometrial Neoplasms Genetic Predisposition to Disease Esophageal Neoplasms Rectal Neoplasms

Chemicals and Drugs86

Antineoplastic Agents Antineoplastic Agents, Phytogenic Cisplatin Doxorubicin RNA, Small Interfering Neoplasm Proteins Antibiotics, Antineoplastic RNA, Messenger Tumor Suppressor Protein p53 Paclitaxel Radiation-Sensitizing Agents Drug Carriers Enzyme Inhibitors Fluorouracil Camptothecin Proto-Oncogene Proteins c-bcl-2 DNA, Neoplasm Caspases Antimetabolites, Antineoplastic P-Glycoprotein Tumor Markers, Biological Etoposide Anticarcinogenic Agents Caspase 3 Proto-Oncogene Proteins c-akt Plant Extracts Receptor, erbB-2 DNA-Binding Proteins Receptor, Epidermal Growth Factor Receptors, Estrogen Ellipticines Tumor Suppressor Proteins Protein-Serine-Threonine Kinases Protein Kinase Inhibitors Cancer Vaccines Tamoxifen Prodrugs Apoptosis Regulatory Proteins Proto-Oncogene Proteins Organoplatinum Compounds Antibodies, Monoclonal RNA, Neoplasm Reactive Oxygen Species Antigens, Neoplasm Deoxycytidine Cell Cycle Proteins Transcription Factors DNA Poly(ADP-ribose) Polymerases Histone Deacetylase Inhibitors MicroRNAs Nuclear Proteins Cyclin-Dependent Kinase Inhibitor p21 Indoles Hydroxamic Acids bcl-2-Associated X Protein Inhibitor of Apoptosis Proteins Topoisomerase I Inhibitors Taxoids Receptors, Androgen Quinazolines Platinum Radiation-Protective Agents Androgens Prostate-Specific Antigen DNA Topoisomerases, Type II TNF-Related Apoptosis-Inducing Ligand Triterpenes Phosphatidylinositol 3-Kinases Antineoplastic Agents, Alkylating Mitomycin NF-kappa B Curcumin Daunorubicin Estrogen Receptor alpha Mitoxantrone TOR Serine-Threonine Kinases Nanocapsules DNA Primers Thiazoles Vinblastine Tubulin Modulators Antineoplastic Agents, Hormonal beta Catenin ATP-Binding Cassette Transporters Sulfonamides

Analytical, Diagnostic and Therapeutic Techniques and Equipment54

Radiation Dosage Drug Screening Assays, Antitumor Dose-Response Relationship, Radiation Xenograft Model Antitumor Assays Radiation Monitoring Blotting, Western Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Drug Delivery Systems Early Detection of Cancer Transplantation, Heterologous Inhibitory Concentration 50 Transfection Combined Modality Therapy Radiotherapy Antineoplastic Combined Chemotherapy Protocols Drug Carriers Flow Cytometry Gene Expression Profiling Tumor Burden Molecular Targeted Therapy Radiation Injuries, Experimental Models, Biological Gene Knockdown Techniques Radiotherapy Dosage Prognosis Tumor Stem Cell Assay Neoplasms, Experimental Drug Design Survival Analysis Oligonucleotide Array Sequence Analysis Immunohistochemistry Radiometry Drug Evaluation, Preclinical Survival Rate Neoplasm Staging Clinical Trials as Topic Retrospective Studies Follow-Up Studies Immunoblotting Genetic Therapy Mammary Neoplasms, Experimental Treatment Outcome Disease-Free Survival Drug Discovery Real-Time Polymerase Chain Reaction Risk Phytotherapy Nanocapsules Radiotherapy, Adjuvant Prospective Studies Sensitivity and Specificity Risk Assessment Chemotherapy, Adjuvant

Phenomena and Processes59

Radiation, Ionizing Radiation Dosage Apoptosis Radiation Tolerance Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Cell Proliferation Cell Survival Radiation Cell Cycle Signal Transduction Cell Division Dose-Response Relationship, Drug Down-Regulation Drug Synergism DNA Damage Inhibitory Concentration 50 Transfection Cell Movement RNA Interference Cell Growth Processes Gamma Rays Drug Resistance, Multiple Phosphorylation Up-Regulation Cosmic Radiation Mutation Time Factors Promoter Regions, Genetic Gene Silencing Cell Death Base Sequence DNA Repair Molecular Structure Ultraviolet Rays Enzyme Activation Gene Expression Background Radiation Cell Cycle Checkpoints Protein Binding Transcription, Genetic Genes, p53 Radiation Effects G2 Phase Phenotype Cell Adhesion Tumor Microenvironment Genetic Predisposition to Disease Epithelial-Mesenchymal Transition Structure-Activity Relationship Risk Autophagy Cell Hypoxia Sensitivity and Specificity Genes, Tumor Suppressor Membrane Potential, Mitochondrial Drug Resistance X-Rays

Disciplines and Occupations6

Radiation Oncology Drug Design Immunohistochemistry Nanomedicine Drug Discovery Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture3

Nanoparticles Nanomedicine Nanocapsules

Information Science3

Base Sequence Molecular Sequence Data Survival Rate

Health Care21

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Cosmic Radiation Radiation Injuries, Experimental Ultraviolet Rays Survival Analysis National Cancer Institute (U.S.)Survival Rate Clinical Trials as Topic Retrospective Studies Follow-Up Studies Radiation Effects Treatment Outcome Disease-Free Survival Risk Prospective Studies Sensitivity and Specificity Risk Assessment

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Agents Cell Line, Tumor Radiation, Ionizing Radiation Dosage Neoplasms Breast Neoplasms Drug Screening Assays, Antitumor Radiation Injuries Apoptosis Radiation Tolerance Tumor Cells, Cultured Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Mice, Nude Cell Proliferation Cell Survival Colonic Neoplasms Radiation Xenograft Model Antitumor Assays Antineoplastic Agents, Phytogenic Radiation Protection Lung Neoplasms Ovarian Neoplasms Radiation Monitoring Neoplasm Invasiveness Cisplatin Doxorubicin Cell Cycle RNA, Small Interfering Neoplasm Proteins Pancreatic Neoplasms Blotting, Western Neoplasm Metastasis Antibiotics, Antineoplastic Signal Transduction Cell Division RNA, Messenger Neoplasm Transplantation Reverse Transcriptase Polymerase Chain Reaction Drug Delivery Systems Dose-Response Relationship, Drug Stomach Neoplasms Early Detection of Cancer Down-Regulation Tumor Suppressor Protein p53 HCT116 Cells Drug Synergism Paclitaxel DNA Damage MCF-7 Cells HT29 Cells Transplantation, Heterologous Radiation Oncology Inhibitory Concentration 50 Transfection Cell Movement Adenocarcinoma Combined Modality Therapy Radiation-Sensitizing Agents RNA Interference Cell Growth Processes Gamma Rays Neoplasms, Radiation-Induced Radiotherapy Antineoplastic Combined Chemotherapy Protocols Drug Carriers Flow Cytometry Prostatic Neoplasms Enzyme Inhibitors Carcinoma Gene Expression Profiling Drug Resistance, Multiple Phosphorylation Fluorouracil Camptothecin Up-Regulation Carcinoma, Squamous Cell Proto-Oncogene Proteins c-bcl-2 DNA, Neoplasm Cosmic Radiation Carcinoma, Non-Small-Cell Lung Mutation Colorectal Neoplasms Tumor Burden Caspases Molecular Targeted Therapy Antimetabolites, Antineoplastic P-Glycoprotein Tumor Markers, Biological Etoposide Radiation Injuries, Experimental Anticarcinogenic Agents Caspase 3 Proto-Oncogene Proteins c-akt Models, Biological Plant Extracts Mice, SCID Cell Transformation, Neoplastic Time Factors

No FAQ available that match "cancer cell cells anticancer drugs or radiation"